FLAGYSTATIN 500 MG
METRONIDAZOLE : 500 MG NYSTATIN : 100000 UNIT · DIN 01926837 · AVENTIS PHARMA INC
Health Canada status: CANCELLED POST MARKET
What is FLAGYSTATIN?
FLAGYSTATIN 500 MG contains METRONIDAZOLE : 500 MG NYSTATIN : 100000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01926837, held by AVENTIS PHARMA INC, supplied as SUPPOSITORY for VAGINAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Jul-2004. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FLAGYSTATIN used for?
Mixed vaginal infection due to Trichomonas vaginalis and Candida albicans.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01926837 |
|---|---|
| Brand name | FLAGYSTATIN |
| Generic / active ingredient | METRONIDAZOLE : 500 MG NYSTATIN : 100000 UNIT |
| Manufacturer | AVENTIS PHARMA INC |
| Strength | 500 MG |
| Dosage form | SUPPOSITORY |
| Route of administration | VAGINAL |
| Schedule | Prescription |
| ATC code | G01AA51 NYSTATIN, COMBINATIONS |
| AHFS class | 84:04.08.28 ; 84:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Jul-2004 |
| Original market date | 1972-12-31 00:00:00 |
How is it administered?
One vaginal ovule daily, inserted deep into the vagina, for 10 consecutive days. A second 10-day course may be given if cure is not achieved.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature between 15 - 25ºC and protect from light.
How is it supplied?
Boxes of 10 ovules with applicator.
Contraindications
Hypersensitivity to metronidazole, nystatin, or imidazoles. Combined oral metronidazole avoided in active neurological disorders, blood dyscrasia, hypothyroidism, or hypoadrenalism.
Warnings and precautions
Metronidazole is carcinogenic in rodents. Risk of severe hepatotoxicity in Cockayne syndrome. Potential for peripheral/central neuropathy. May impair condoms/diaphragms.
What can be used instead?
Other Canadian products sharing ATC code G01AA51 NYSTATIN, COMBINATIONS. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLAGYSTATIN | 100000 UNIT | OVULE | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 01926829 |
| FLAGYSTATIN | 100000 UNIT / 4.5 G | CREAM | SANOFI-AVENTIS CANADA INC | CANCELLED POST MARKET | DIN 01926845 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.